Interestingly, high CHCHD4 expression in breast cancer and glioma patient tumours was shown to significantly correlate with the hypoxia gene signature, metastasis and decreased survival of patients with these cancers [16,83], suggesting a critical role for CHCHD4 in regulating hypoxia signalling and cancer progression. The gene discussed is CHCHD4; the disease is central nervous system cancer.